EmilySlotkinMD

Pediatric Hematology & Oncology • New York, NY

Pediatric Sarcoma Oncology

Physician

Overview of Dr. Slotkin

Dr. Emily Slotkin is a pediatric hematologist/oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University at Buffalo School of Medicine and has been in practice 12 years. She is one of 92 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. She has more than 20 publications and over 500 citings.

Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021
Book by Phone+1(970) 344-4153
Is this information wrong?

Education & Training

Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2008 - 2011
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2008
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology

Certifications & Licensure

FL State Medical License 2021 - Present
NJ State Medical License 2024 - 2025
NY State Medical License 2011 - 2024
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma
Available
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor Start of enrollment: 2020 Dec 22
Recruiting
A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor Start of enrollment: 2022 Mar 02
Recruiting
Phase 2
Roles: Contact, Principal Investigator
A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum Start of enrollment: 2019 Jul 15
Recruiting
Phase 2
Roles: Principal Investigator, Contact
A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors Start of enrollment: 2020 Dec 10
Terminated
Phase 2
Roles: Contact
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 Start of enrollment: 2022 Nov 17
Recruiting
Phase 1
Roles: Contact
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer Start of enrollment: 2021 Aug 09
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Chromoplexy is a frequent early clonal event in EWSR1-rearranged round cell sarcomas that can be detected using clinically validated targeted sequencing panels.
Healey, J., Vanoli, F., Vanderbilt, C., Dermawan, J., Slotkin, E., Tap, W., Meyers, P., Wexler, L., Antonescu, C.> ;Cancer Research. 2024 Feb 9
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaborat...
Andrew D J Pearson, Sara Federico, Susanne A Gatz, Michael Ortiz, Giovanni Lesa, Nicole Scobie, Ioannis Gounaris, Susan L Weiner, Brenda Weigel, T J Unger, Elizabeth S...> ;European Journal of Cancer. 2023 Sep 1
1 citations
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA.
Peter Anderson, Maurizio Ghisoli, Brian D Crompton, Kelly S Klega, Leonard H Wexler, Emily K Slotkin, Laura Stanbery, Luisa Manning, Gladice Wallraven, Meghan Manley, ...> ;Clinical Cancer Research. 2023 May 1
1 citations
Irinotecan dose schedule for the treatment of Ewing sarcoma.
Emily K Slotkin, Paul A Meyers> ;Pediatric Blood & Cancer. 2023 Jan 1
Towards a new era in the treatment of Ewing sarcoma.
Emily K Slotkin, William D Tap> ;Lancet. 2022 Oct 29
6 citations
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Fo...
Sarah B. Whittle, Katharine Offer, Ryan D. Roberts, Amy K. LeBlanc, Cheryl A. London, Robbie G. Majzner, Alex Yee-Chen Huang, Peter J. Houghton, E. Alejandro Sweet Cor...> ;Pediatric Blood & Cancer. 2021 Jun 16
21 citations
TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma.
Dana L. Casey, Kenneth L. Pitter, Leonard H. Wexler, Emily K. Slotkin, Gaorav P. Gupta, Suzanne L. Wolden> ;British Journal of Cancer. 2021 May 20
11 citations
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
, , , , , , , , , , , , , , , , , , , , , , > ;Molecular Cancer Research. 2021 Mar 22
66 citations
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Nature Cancer. 2021 Feb 15
1 citations
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors
Leo Mascarenhas, Chitose Ogawa, Theodore W. Laetsch, Brenda J. Weigel, Michael W. Bishop, Julie Krystal, Scott C. Borinstein, Emily K. Slotkin, Jodi A. Muscal, Pooja H...> ;Cancer Medicine. 2021 Jan 20
34 citations
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase...
Shakeel Modak, Pat Zanzonico, Milan Grkovski, Emily K. Slotkin, Jorge A. Carrasquillo, Serge K. Lyashchenko, Jason S. Lewis, Irene Y. Cheung, Todd E. Heaton, Michael P...> ;Journal of Clinical Oncology. 2020 Oct 29
11 citations
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome.
Evan Rosenbaum, Kenneth Seier, Chaitanya Bandlamudi, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Ping Chi, Ciara Marie Kelly, Sujana Movva, Benjamin A. Nac...> ;Clinical Cancer Research. 2020 Aug 14
569 citations
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Ayuko Hoshino, Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi, Jonathan M. Hernandez, Constantinos P. Zambirinis, Gonçalo Rodrigues, Henrik Molina, Søren H...> ;Cell. 2020 Aug 20
31 citations
Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma
Dana L. Casey, Leonard H. Wexler, Kenneth L. Pitter, Robert M. Samstein, Emily K. Slotkin, Suzanne L. Wolden> ;Clinical Cancer Research. 2020 Mar 1
9 citations
A novel image-based system for risk stratification in patients with desmoplastic small round cell tumor
James A. Saltsman, Anita P. Price, Debra A. Goldman, William J. Hammond, Enrico Danzer, Emily K. Slotkin, William D. Tap, Todd E. Heaton, Shakeel Modak, Michael P. LaQ...> ;Journal of Pediatric Surgery. 2020 Mar 1
66 citations
Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations.
, , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2019 Jan 1
Entrectinib in Two Pediatric Patients With Inflammatory Myofibroblastic Tumors HarboringorGene Fusions.
Srikanth R Ambati, Emily K Slotkin, Edna Chow-Maneval, Ellen M Basu> ;JCO precision oncology. 2018 Jan 1
Entrectinib in Two Pediatric Patients With Inflammatory Myofibroblastic Tumors HarboringorGene Fusions.
Srikanth R Ambati, Emily K Slotkin, Edna Chow-Maneval, Ellen M Basu> ;JCO Precision Oncology. 2018 Jan 1
2 citations
Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma.
Michael V. Ortiz, Heather Magnan, Emily K. Slotkin, Srikanth R. Ambati, Alexander J. Chou, Leonard H. Wexler, Paul A. Meyers, Michael Walsh, Todd E. Heaton, Leonard N....> ;Journal of Pediatric Hematology/oncology. 2017 Nov 1
41 citations
Plasma DNA-Based Molecular Diagnosis, Prognostication, and Monitoring of Patients With EWSR1 Fusion-Positive Sarcomas
Neerav Shukla, Juber Patel, Heather Magnan, Ahmet Zehir, Daoqi You, Jiabin Tang, Fanli Meng, Aliaksandra Samoila, Emily K. Slotkin, Srikanth R. Ambati, Alexander J. Ch...> ;JCO Precision Oncology. 2017 May 23
22 citations
Generation of conditional oncogenic chromosomal translocations using CRISPR–Cas9 genomic editing and homology‐directed repair
Lee Spraggon, Luciano G. Martelotto, Julija Hmeljak, Tyler D. Hitchman, Jiang Wang, Lu Wang, Emily K. Slotkin, Pang-Dian Fan, Jorge S. Reis-Filho, Marc Ladanyi> ;The Journal of Pathology. 2017 May 1
1 citations
A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predisposition
Melissa Mathias, Michael V. Ortiz, Heather D. Magnan, Srikanth R. Ambati, Emily K. Slotkin, Alexander J. Chou, Michael Walsh, Kenneth Offit, Chaya S. Moskowitz, Alex K...> ;Biomarker Research. 2017 Feb 8
11 citations
A single‐center experience with undifferentiated embryonal sarcoma of the liver
Melissa Mathias, Srikanth R. Ambati, Alexander J. Chou, Emily K. Slotkin, Leonard H. Wexler, Paul A. Meyers, Heather Magnan> ;Pediatric Blood & Cancer. 2016 Jul 18
33 citations
Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center
Michael V. Ortiz, Rachel Kobos, Michael Walsh, Emily K. Slotkin, Stephen S. Roberts, Michael F. Berger, Meera Hameed, David B. Solit, Marc Ladanyi, Alex Kentsis> ;Pediatric Blood & Cancer. 2016 Apr 15
76 citations
MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent In Vitro and In Vivo Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma
Emily K. Slotkin, Parag Patwardhan, Shyamprasad Deraje Vasudeva, Elisa de Stanchina, William D. Tap, Gary K. Schwartz> ;Molecular Cancer Therapeutics. 2015 Feb 1
Join now to see all

Press Mentions

Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to Clinical Trials?December 9th, 2022

Hospital Affiliations

Memorial Sloan Kettering Cancer CenterNew York, New York